nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—hypertension—obesity	0.41	1	CtDrD
Spironolactone—CYP11B1—Cimetidine—obesity	0.125	0.73	CbGbCtD
Spironolactone—SHBG—obesity	0.109	0.405	CbGaD
Spironolactone—AR—obesity	0.0953	0.355	CbGaD
Spironolactone—NR3C1—obesity	0.0646	0.241	CbGaD
Spironolactone—CYP2C8—Bupropion—obesity	0.0208	0.121	CbGbCtD
Spironolactone—CYP2C8—Cimetidine—obesity	0.0153	0.0888	CbGbCtD
Spironolactone—ABCB1—Cimetidine—obesity	0.0103	0.0601	CbGbCtD
Spironolactone—PGR—ovarian follicle—obesity	0.00367	0.128	CbGeAlD
Spironolactone—ABCC2—bile—obesity	0.00242	0.0844	CbGeAlD
Spironolactone—Breast cancer—Bupropion—obesity	0.00112	0.0198	CcSEcCtD
Spironolactone—CYP11B1—adrenal cortex—obesity	0.000991	0.0345	CbGeAlD
Spironolactone—CYP11B2—adrenal cortex—obesity	0.000991	0.0345	CbGeAlD
Spironolactone—CYP11B2—cardiovascular system—obesity	0.000905	0.0315	CbGeAlD
Spironolactone—SHBG—hindbrain—obesity	0.000881	0.0307	CbGeAlD
Spironolactone—Menstruation irregular—Orlistat—obesity	0.000874	0.0155	CcSEcCtD
Spironolactone—NR3C2—hindbrain—obesity	0.000854	0.0297	CbGeAlD
Spironolactone—Erectile dysfunction—Methamphetamine—obesity	0.000852	0.0151	CcSEcCtD
Spironolactone—Gynaecomastia—Diethylpropion—obesity	0.000825	0.0146	CcSEcCtD
Spironolactone—Gastrointestinal symptom NOS—Orlistat—obesity	0.000823	0.0146	CcSEcCtD
Spironolactone—PGR—hindbrain—obesity	0.000793	0.0276	CbGeAlD
Spironolactone—Gynaecomastia—Cimetidine—obesity	0.000785	0.0139	CcSEcCtD
Spironolactone—Ataxia—Phenylpropanolamine—obesity	0.000756	0.0134	CcSEcCtD
Spironolactone—Menstruation irregular—Bupropion—obesity	0.000738	0.0131	CcSEcCtD
Spironolactone—Breast enlargement—Sibutramine—obesity	0.000722	0.0128	CcSEcCtD
Spironolactone—CYP11B1—adrenal gland—obesity	0.000715	0.0249	CbGeAlD
Spironolactone—CYP11B2—adrenal gland—obesity	0.000715	0.0249	CbGeAlD
Spironolactone—Hypertrichosis—Topiramate—obesity	0.000685	0.0121	CcSEcCtD
Spironolactone—Breast enlargement—Bupropion—obesity	0.00063	0.0112	CcSEcCtD
Spironolactone—CYP11B1—endocrine gland—obesity	0.00062	0.0216	CbGeAlD
Spironolactone—CYP11B2—endocrine gland—obesity	0.00062	0.0216	CbGeAlD
Spironolactone—Drowsiness—Phenylpropanolamine—obesity	0.000619	0.011	CcSEcCtD
Spironolactone—Erectile dysfunction—Phentermine—obesity	0.000612	0.0108	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Cimetidine—obesity	0.000573	0.0102	CcSEcCtD
Spironolactone—Amenorrhoea—Orlistat—obesity	0.000551	0.00976	CcSEcCtD
Spironolactone—Rash erythematous—Bupropion—obesity	0.000533	0.00945	CcSEcCtD
Spironolactone—Amenorrhoea—Sibutramine—obesity	0.000533	0.00945	CcSEcCtD
Spironolactone—Erectile dysfunction—Diethylpropion—obesity	0.000532	0.00943	CcSEcCtD
Spironolactone—Drowsiness—Diethylpropion—obesity	0.000516	0.00913	CcSEcCtD
Spironolactone—Erectile dysfunction—Cimetidine—obesity	0.000507	0.00898	CcSEcCtD
Spironolactone—Drowsiness—Cimetidine—obesity	0.00049	0.00869	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Cimetidine—obesity	0.000486	0.00862	CcSEcCtD
Spironolactone—PGR—respiratory system—obesity	0.000485	0.0169	CbGeAlD
Spironolactone—Renal failure—Cimetidine—obesity	0.000482	0.00854	CcSEcCtD
Spironolactone—Agranulocytosis—Diethylpropion—obesity	0.000481	0.00852	CcSEcCtD
Spironolactone—Amenorrhoea—Bupropion—obesity	0.000465	0.00824	CcSEcCtD
Spironolactone—Hyperkalaemia—Sibutramine—obesity	0.00046	0.00816	CcSEcCtD
Spironolactone—NR3C1—hindbrain—obesity	0.000458	0.0159	CbGeAlD
Spironolactone—Agranulocytosis—Cimetidine—obesity	0.000458	0.00811	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Methamphetamine—obesity	0.000454	0.00805	CcSEcCtD
Spironolactone—Cramps of lower extremities—Orlistat—obesity	0.000445	0.00788	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Benzphetamine—obesity	0.000438	0.00776	CcSEcCtD
Spironolactone—NR3C2—adrenal cortex—obesity	0.000437	0.0152	CbGeAlD
Spironolactone—Cramps of lower extremities—Sibutramine—obesity	0.00043	0.00763	CcSEcCtD
Spironolactone—Urticaria—Methamphetamine—obesity	0.000418	0.0074	CcSEcCtD
Spironolactone—Erythema multiforme—Cimetidine—obesity	0.000416	0.00738	CcSEcCtD
Spironolactone—SHBG—cardiovascular system—obesity	0.000412	0.0143	CbGeAlD
Spironolactone—Alopecia—Diethylpropion—obesity	0.000409	0.00725	CcSEcCtD
Spironolactone—Urticaria—Benzphetamine—obesity	0.000403	0.00714	CcSEcCtD
Spironolactone—NR3C2—cardiovascular system—obesity	0.000399	0.0139	CbGeAlD
Spironolactone—Confusional state—Phenylpropanolamine—obesity	0.000398	0.00706	CcSEcCtD
Spironolactone—Alopecia—Cimetidine—obesity	0.000389	0.00689	CcSEcCtD
Spironolactone—Hypersensitivity—Methamphetamine—obesity	0.000388	0.00687	CcSEcCtD
Spironolactone—Cramps of lower extremities—Bupropion—obesity	0.000375	0.00665	CcSEcCtD
Spironolactone—Ill-defined disorder—Diethylpropion—obesity	0.000374	0.00662	CcSEcCtD
Spironolactone—Hypersensitivity—Benzphetamine—obesity	0.000374	0.00662	CcSEcCtD
Spironolactone—PGR—cardiovascular system—obesity	0.000371	0.0129	CbGeAlD
Spironolactone—Gynaecomastia—Bupropion—obesity	0.000365	0.00647	CcSEcCtD
Spironolactone—SHBG—pituitary gland—obesity	0.000365	0.0127	CbGeAlD
Spironolactone—SHBG—adipose tissue—obesity	0.000363	0.0126	CbGeAlD
Spironolactone—Malaise—Diethylpropion—obesity	0.000363	0.00644	CcSEcCtD
Spironolactone—Leukopenia—Diethylpropion—obesity	0.000361	0.00639	CcSEcCtD
Spironolactone—Diarrhoea—Methamphetamine—obesity	0.00036	0.00638	CcSEcCtD
Spironolactone—NR3C2—pituitary gland—obesity	0.000353	0.0123	CbGeAlD
Spironolactone—NR3C2—adipose tissue—obesity	0.000352	0.0123	CbGeAlD
Spironolactone—Somnolence—Phenylpropanolamine—obesity	0.000351	0.00622	CcSEcCtD
Spironolactone—Dizziness—Methamphetamine—obesity	0.000348	0.00616	CcSEcCtD
Spironolactone—Diarrhoea—Benzphetamine—obesity	0.000347	0.00615	CcSEcCtD
Spironolactone—Malaise—Cimetidine—obesity	0.000346	0.00612	CcSEcCtD
Spironolactone—Leukopenia—Cimetidine—obesity	0.000343	0.00608	CcSEcCtD
Spironolactone—Rash erythematous—Topiramate—obesity	0.00034	0.00602	CcSEcCtD
Spironolactone—Discomfort—Diethylpropion—obesity	0.000339	0.006	CcSEcCtD
Spironolactone—Dizziness—Benzphetamine—obesity	0.000335	0.00594	CcSEcCtD
Spironolactone—NR3C2—digestive system—obesity	0.000331	0.0115	CbGeAlD
Spironolactone—Headache—Methamphetamine—obesity	0.00033	0.00584	CcSEcCtD
Spironolactone—PGR—pituitary gland—obesity	0.000329	0.0114	CbGeAlD
Spironolactone—PGR—adipose tissue—obesity	0.000327	0.0114	CbGeAlD
Spironolactone—Gastrointestinal disorder—Phentermine—obesity	0.000326	0.00578	CcSEcCtD
Spironolactone—SHBG—adrenal gland—obesity	0.000326	0.0113	CbGeAlD
Spironolactone—Feeling abnormal—Phenylpropanolamine—obesity	0.000325	0.00577	CcSEcCtD
Spironolactone—AR—adrenal cortex—obesity	0.000324	0.0113	CbGeAlD
Spironolactone—Ataxia—Sibutramine—obesity	0.00032	0.00567	CcSEcCtD
Spironolactone—Headache—Benzphetamine—obesity	0.000318	0.00563	CcSEcCtD
Spironolactone—Cramp muscle—Orlistat—obesity	0.000316	0.00561	CcSEcCtD
Spironolactone—Diarrhoea—Phendimetrazine—obesity	0.000316	0.0056	CcSEcCtD
Spironolactone—NR3C2—adrenal gland—obesity	0.000316	0.011	CbGeAlD
Spironolactone—Confusional state—Cimetidine—obesity	0.000315	0.00559	CcSEcCtD
Spironolactone—Anaphylactic shock—Cimetidine—obesity	0.000313	0.00554	CcSEcCtD
Spironolactone—Gastritis—Orlistat—obesity	0.000311	0.00551	CcSEcCtD
Spironolactone—Thrombocytopenia—Cimetidine—obesity	0.000306	0.00543	CcSEcCtD
Spironolactone—Dizziness—Phendimetrazine—obesity	0.000306	0.00542	CcSEcCtD
Spironolactone—Lethargy—Bupropion—obesity	0.000303	0.00536	CcSEcCtD
Spironolactone—Nausea—Benzphetamine—obesity	0.000301	0.00534	CcSEcCtD
Spironolactone—Gastritis—Sibutramine—obesity	0.000301	0.00533	CcSEcCtD
Spironolactone—Urticaria—Phentermine—obesity	0.0003	0.00532	CcSEcCtD
Spironolactone—Breast pain—Topiramate—obesity	0.000298	0.00528	CcSEcCtD
Spironolactone—Amenorrhoea—Topiramate—obesity	0.000296	0.00525	CcSEcCtD
Spironolactone—NR3C1—islet of Langerhans—obesity	0.000296	0.0103	CbGeAlD
Spironolactone—AR—cardiovascular system—obesity	0.000296	0.0103	CbGeAlD
Spironolactone—PGR—adrenal gland—obesity	0.000294	0.0102	CbGeAlD
Spironolactone—Somnolence—Diethylpropion—obesity	0.000292	0.00518	CcSEcCtD
Spironolactone—Eosinophilia—Sibutramine—obesity	0.000291	0.00516	CcSEcCtD
Spironolactone—Hypersensitivity—Phenylpropanolamine—obesity	0.000291	0.00516	CcSEcCtD
Spironolactone—Headache—Phendimetrazine—obesity	0.00029	0.00513	CcSEcCtD
Spironolactone—SLCO1A2—digestive system—obesity	0.000284	0.00989	CbGeAlD
Spironolactone—Gastrointestinal disorder—Diethylpropion—obesity	0.000284	0.00503	CcSEcCtD
Spironolactone—SHBG—endocrine gland—obesity	0.000283	0.00984	CbGeAlD
Spironolactone—NR3C1—respiratory system—obesity	0.00028	0.00974	CbGeAlD
Spironolactone—Ataxia—Bupropion—obesity	0.000279	0.00494	CcSEcCtD
Spironolactone—Somnolence—Cimetidine—obesity	0.000278	0.00493	CcSEcCtD
Spironolactone—Nausea—Phendimetrazine—obesity	0.000275	0.00487	CcSEcCtD
Spironolactone—NR3C2—endocrine gland—obesity	0.000274	0.00954	CbGeAlD
Spironolactone—Feeling abnormal—Diethylpropion—obesity	0.000271	0.0048	CcSEcCtD
Spironolactone—Erectile dysfunction—Sibutramine—obesity	0.000271	0.0048	CcSEcCtD
Spironolactone—Cramp muscle—Bupropion—obesity	0.000267	0.00473	CcSEcCtD
Spironolactone—Renal failure—Orlistat—obesity	0.000266	0.00472	CcSEcCtD
Spironolactone—ABCC2—digestive system—obesity	0.000265	0.00921	CbGeAlD
Spironolactone—Gastritis—Bupropion—obesity	0.000262	0.00465	CcSEcCtD
Spironolactone—AR—pituitary gland—obesity	0.000262	0.00912	CbGeAlD
Spironolactone—Urticaria—Diethylpropion—obesity	0.000261	0.00463	CcSEcCtD
Spironolactone—Dizziness—Phenylpropanolamine—obesity	0.000261	0.00463	CcSEcCtD
Spironolactone—AR—adipose tissue—obesity	0.000261	0.00908	CbGeAlD
Spironolactone—Diarrhoea—Phentermine—obesity	0.000259	0.00458	CcSEcCtD
Spironolactone—Feeling abnormal—Cimetidine—obesity	0.000258	0.00457	CcSEcCtD
Spironolactone—Renal failure—Sibutramine—obesity	0.000258	0.00456	CcSEcCtD
Spironolactone—SHBG—liver—obesity	0.000255	0.00887	CbGeAlD
Spironolactone—PGR—endocrine gland—obesity	0.000255	0.00886	CbGeAlD
Spironolactone—ABCC2—adrenal gland—obesity	0.000252	0.00878	CbGeAlD
Spironolactone—Vomiting—Phenylpropanolamine—obesity	0.000251	0.00445	CcSEcCtD
Spironolactone—Dizziness—Phentermine—obesity	0.00025	0.00443	CcSEcCtD
Spironolactone—Rash—Phenylpropanolamine—obesity	0.000249	0.00441	CcSEcCtD
Spironolactone—Dermatitis—Phenylpropanolamine—obesity	0.000249	0.00441	CcSEcCtD
Spironolactone—Body temperature increased—Cimetidine—obesity	0.000247	0.00438	CcSEcCtD
Spironolactone—NR3C2—liver—obesity	0.000247	0.0086	CbGeAlD
Spironolactone—AR—digestive system—obesity	0.000245	0.00855	CbGeAlD
Spironolactone—Vomiting—Phentermine—obesity	0.00024	0.00426	CcSEcCtD
Spironolactone—Cramps of lower extremities—Topiramate—obesity	0.000239	0.00424	CcSEcCtD
Spironolactone—Rash—Phentermine—obesity	0.000238	0.00422	CcSEcCtD
Spironolactone—Dermatitis—Phentermine—obesity	0.000238	0.00422	CcSEcCtD
Spironolactone—Headache—Phentermine—obesity	0.000237	0.00419	CcSEcCtD
Spironolactone—Erectile dysfunction—Bupropion—obesity	0.000236	0.00418	CcSEcCtD
Spironolactone—SLCO1A2—endocrine gland—obesity	0.000235	0.00817	CbGeAlD
Spironolactone—NR3C1—adrenal cortex—obesity	0.000235	0.00817	CbGeAlD
Spironolactone—Nausea—Phenylpropanolamine—obesity	0.000235	0.00416	CcSEcCtD
Spironolactone—AR—adrenal gland—obesity	0.000234	0.00814	CbGeAlD
Spironolactone—Hypersensitivity—Cimetidine—obesity	0.00023	0.00408	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Bupropion—obesity	0.000227	0.00401	CcSEcCtD
Spironolactone—Oxandrolone—AR—obesity	0.000226	0.0842	CrCbGaD
Spironolactone—Diarrhoea—Diethylpropion—obesity	0.000225	0.00399	CcSEcCtD
Spironolactone—Nausea—Phentermine—obesity	0.000224	0.00398	CcSEcCtD
Spironolactone—ABCC2—endocrine gland—obesity	0.000219	0.00761	CbGeAlD
Spironolactone—Dizziness—Diethylpropion—obesity	0.000217	0.00385	CcSEcCtD
Spironolactone—Alopecia—Orlistat—obesity	0.000215	0.00381	CcSEcCtD
Spironolactone—NR3C1—cardiovascular system—obesity	0.000214	0.00746	CbGeAlD
Spironolactone—Diarrhoea—Cimetidine—obesity	0.000214	0.00379	CcSEcCtD
Spironolactone—CYP2C8—pituitary gland—obesity	0.000212	0.00737	CbGeAlD
Spironolactone—SLCO1A2—liver—obesity	0.000212	0.00737	CbGeAlD
Spironolactone—Vomiting—Diethylpropion—obesity	0.000209	0.0037	CcSEcCtD
Spironolactone—Alopecia—Sibutramine—obesity	0.000208	0.00368	CcSEcCtD
Spironolactone—Rash—Diethylpropion—obesity	0.000207	0.00367	CcSEcCtD
Spironolactone—Dermatitis—Diethylpropion—obesity	0.000207	0.00367	CcSEcCtD
Spironolactone—Dizziness—Cimetidine—obesity	0.000207	0.00367	CcSEcCtD
Spironolactone—Headache—Diethylpropion—obesity	0.000206	0.00365	CcSEcCtD
Spironolactone—Muscle spasms—Orlistat—obesity	0.000203	0.0036	CcSEcCtD
Spironolactone—AR—endocrine gland—obesity	0.000203	0.00706	CbGeAlD
Spironolactone—Vomiting—Cimetidine—obesity	0.000199	0.00352	CcSEcCtD
Spironolactone—Rash—Cimetidine—obesity	0.000197	0.00349	CcSEcCtD
Spironolactone—ABCC2—liver—obesity	0.000197	0.00687	CbGeAlD
Spironolactone—Dermatitis—Cimetidine—obesity	0.000197	0.00349	CcSEcCtD
Spironolactone—Muscle spasms—Sibutramine—obesity	0.000197	0.00349	CcSEcCtD
Spironolactone—Ill-defined disorder—Orlistat—obesity	0.000196	0.00348	CcSEcCtD
Spironolactone—Headache—Cimetidine—obesity	0.000196	0.00347	CcSEcCtD
Spironolactone—Nausea—Diethylpropion—obesity	0.000195	0.00346	CcSEcCtD
Spironolactone—Erythema multiforme—Bupropion—obesity	0.000194	0.00344	CcSEcCtD
Spironolactone—Lethargy—Topiramate—obesity	0.000193	0.00342	CcSEcCtD
Spironolactone—Malaise—Orlistat—obesity	0.000191	0.00338	CcSEcCtD
Spironolactone—Ill-defined disorder—Sibutramine—obesity	0.00019	0.00337	CcSEcCtD
Spironolactone—NR3C1—pituitary gland—obesity	0.00019	0.0066	CbGeAlD
Spironolactone—NR3C1—adipose tissue—obesity	0.000189	0.00658	CbGeAlD
Spironolactone—Nausea—Cimetidine—obesity	0.000186	0.00329	CcSEcCtD
Spironolactone—Malaise—Sibutramine—obesity	0.000185	0.00327	CcSEcCtD
Spironolactone—Leukopenia—Sibutramine—obesity	0.000183	0.00325	CcSEcCtD
Spironolactone—AR—liver—obesity	0.000183	0.00637	CbGeAlD
Spironolactone—Alopecia—Bupropion—obesity	0.000181	0.00321	CcSEcCtD
Spironolactone—Discomfort—Orlistat—obesity	0.000178	0.00315	CcSEcCtD
Spironolactone—NR3C1—digestive system—obesity	0.000178	0.00619	CbGeAlD
Spironolactone—Ataxia—Topiramate—obesity	0.000178	0.00315	CcSEcCtD
Spironolactone—Anaphylactic shock—Orlistat—obesity	0.000173	0.00306	CcSEcCtD
Spironolactone—Discomfort—Sibutramine—obesity	0.000172	0.00305	CcSEcCtD
Spironolactone—Muscle spasms—Bupropion—obesity	0.000172	0.00304	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Topiramate—obesity	0.00017	0.00301	CcSEcCtD
Spironolactone—NR3C1—adrenal gland—obesity	0.000169	0.0059	CbGeAlD
Spironolactone—Confusional state—Sibutramine—obesity	0.000169	0.00299	CcSEcCtD
Spironolactone—Gastritis—Topiramate—obesity	0.000167	0.00296	CcSEcCtD
Spironolactone—Anaphylactic shock—Sibutramine—obesity	0.000167	0.00296	CcSEcCtD
Spironolactone—Ill-defined disorder—Bupropion—obesity	0.000166	0.00294	CcSEcCtD
Spironolactone—CYP2C8—endocrine gland—obesity	0.000164	0.00571	CbGeAlD
Spironolactone—Thrombocytopenia—Sibutramine—obesity	0.000164	0.0029	CcSEcCtD
Spironolactone—Eosinophilia—Topiramate—obesity	0.000162	0.00286	CcSEcCtD
Spironolactone—Malaise—Bupropion—obesity	0.000161	0.00285	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—AKR1C3—obesity	0.00016	0.0597	CrCbGaD
Spironolactone—Leukopenia—Bupropion—obesity	0.00016	0.00283	CcSEcCtD
Spironolactone—ABCB1—islet of Langerhans—obesity	0.000159	0.00552	CbGeAlD
Spironolactone—Erectile dysfunction—Topiramate—obesity	0.00015	0.00266	CcSEcCtD
Spironolactone—Discomfort—Bupropion—obesity	0.00015	0.00266	CcSEcCtD
Spironolactone—ABCB1—respiratory system—obesity	0.00015	0.00521	CbGeAlD
Spironolactone—Gastrointestinal disorder—Orlistat—obesity	0.000149	0.00264	CcSEcCtD
Spironolactone—Somnolence—Sibutramine—obesity	0.000149	0.00263	CcSEcCtD
Spironolactone—CYP2C8—liver—obesity	0.000148	0.00515	CbGeAlD
Spironolactone—Confusional state—Bupropion—obesity	0.000147	0.0026	CcSEcCtD
Spironolactone—NR3C1—endocrine gland—obesity	0.000147	0.00511	CbGeAlD
Spironolactone—Anaphylactic shock—Bupropion—obesity	0.000146	0.00258	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Topiramate—obesity	0.000144	0.00256	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Sibutramine—obesity	0.000144	0.00256	CcSEcCtD
Spironolactone—Renal failure—Topiramate—obesity	0.000143	0.00254	CcSEcCtD
Spironolactone—Thrombocytopenia—Bupropion—obesity	0.000143	0.00253	CcSEcCtD
Spironolactone—Feeling abnormal—Orlistat—obesity	0.000142	0.00252	CcSEcCtD
Spironolactone—Testolactone—CYP19A1—obesity	0.000141	0.0526	CrCbGaD
Spironolactone—Feeling abnormal—Sibutramine—obesity	0.000138	0.00244	CcSEcCtD
Spironolactone—Urticaria—Orlistat—obesity	0.000137	0.00243	CcSEcCtD
Spironolactone—Body temperature increased—Orlistat—obesity	0.000137	0.00242	CcSEcCtD
Spironolactone—Agranulocytosis—Topiramate—obesity	0.000136	0.00241	CcSEcCtD
Spironolactone—Urticaria—Sibutramine—obesity	0.000133	0.00235	CcSEcCtD
Spironolactone—NR3C1—liver—obesity	0.000132	0.00461	CbGeAlD
Spironolactone—Body temperature increased—Sibutramine—obesity	0.000132	0.00234	CcSEcCtD
Spironolactone—Somnolence—Bupropion—obesity	0.00013	0.0023	CcSEcCtD
Spironolactone—Hypersensitivity—Orlistat—obesity	0.000127	0.00225	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Bupropion—obesity	0.000126	0.00223	CcSEcCtD
Spironolactone—ABCB1—adrenal cortex—obesity	0.000126	0.00437	CbGeAlD
Spironolactone—Erythema multiforme—Topiramate—obesity	0.000124	0.00219	CcSEcCtD
Spironolactone—Hypersensitivity—Sibutramine—obesity	0.000123	0.00218	CcSEcCtD
Spironolactone—Testosterone Propionate—COMT—obesity	0.000123	0.0458	CrCbGaD
Spironolactone—Pruritus—Orlistat—obesity	0.000122	0.00216	CcSEcCtD
Spironolactone—Feeling abnormal—Bupropion—obesity	0.00012	0.00213	CcSEcCtD
Spironolactone—Pruritus—Sibutramine—obesity	0.000118	0.0021	CcSEcCtD
Spironolactone—Diarrhoea—Orlistat—obesity	0.000118	0.00209	CcSEcCtD
Spironolactone—Urticaria—Bupropion—obesity	0.000116	0.00205	CcSEcCtD
Spironolactone—Alopecia—Topiramate—obesity	0.000115	0.00205	CcSEcCtD
Spironolactone—Body temperature increased—Bupropion—obesity	0.000115	0.00204	CcSEcCtD
Spironolactone—ABCB1—cardiovascular system—obesity	0.000115	0.00399	CbGeAlD
Spironolactone—Diarrhoea—Sibutramine—obesity	0.000114	0.00203	CcSEcCtD
Spironolactone—Dizziness—Orlistat—obesity	0.000114	0.00202	CcSEcCtD
Spironolactone—Dizziness—Sibutramine—obesity	0.000111	0.00196	CcSEcCtD
Spironolactone—Vomiting—Orlistat—obesity	0.00011	0.00195	CcSEcCtD
Spironolactone—Muscle spasms—Topiramate—obesity	0.000109	0.00194	CcSEcCtD
Spironolactone—Drospirenone—AR—obesity	0.000109	0.0407	CrCbGaD
Spironolactone—Rash—Orlistat—obesity	0.000109	0.00193	CcSEcCtD
Spironolactone—Dermatitis—Orlistat—obesity	0.000109	0.00193	CcSEcCtD
Spironolactone—Headache—Orlistat—obesity	0.000108	0.00192	CcSEcCtD
Spironolactone—Hypersensitivity—Bupropion—obesity	0.000107	0.0019	CcSEcCtD
Spironolactone—Vomiting—Sibutramine—obesity	0.000106	0.00188	CcSEcCtD
Spironolactone—Ill-defined disorder—Topiramate—obesity	0.000106	0.00187	CcSEcCtD
Spironolactone—Rash—Sibutramine—obesity	0.000105	0.00187	CcSEcCtD
Spironolactone—Dermatitis—Sibutramine—obesity	0.000105	0.00187	CcSEcCtD
Spironolactone—Headache—Sibutramine—obesity	0.000105	0.00186	CcSEcCtD
Spironolactone—Pruritus—Bupropion—obesity	0.000103	0.00183	CcSEcCtD
Spironolactone—Fludrocortisone—AR—obesity	0.000103	0.0383	CrCbGaD
Spironolactone—Nausea—Orlistat—obesity	0.000103	0.00182	CcSEcCtD
Spironolactone—Malaise—Topiramate—obesity	0.000103	0.00182	CcSEcCtD
Spironolactone—Leukopenia—Topiramate—obesity	0.000102	0.0018	CcSEcCtD
Spironolactone—ABCB1—pituitary gland—obesity	0.000102	0.00353	CbGeAlD
Spironolactone—ABCB1—adipose tissue—obesity	0.000101	0.00352	CbGeAlD
Spironolactone—Diarrhoea—Bupropion—obesity	9.97e-05	0.00177	CcSEcCtD
Spironolactone—Nausea—Sibutramine—obesity	9.93e-05	0.00176	CcSEcCtD
Spironolactone—Fluoxymesterone—SHBG—obesity	9.68e-05	0.0361	CrCbGaD
Spironolactone—Dizziness—Bupropion—obesity	9.64e-05	0.00171	CcSEcCtD
Spironolactone—Discomfort—Topiramate—obesity	9.57e-05	0.0017	CcSEcCtD
Spironolactone—ABCB1—digestive system—obesity	9.52e-05	0.00331	CbGeAlD
Spironolactone—Confusional state—Topiramate—obesity	9.36e-05	0.00166	CcSEcCtD
Spironolactone—Vomiting—Bupropion—obesity	9.26e-05	0.00164	CcSEcCtD
Spironolactone—Rash—Bupropion—obesity	9.19e-05	0.00163	CcSEcCtD
Spironolactone—Dermatitis—Bupropion—obesity	9.18e-05	0.00163	CcSEcCtD
Spironolactone—Testosterone Propionate—AR—obesity	9.16e-05	0.0342	CrCbGaD
Spironolactone—Headache—Bupropion—obesity	9.13e-05	0.00162	CcSEcCtD
Spironolactone—Drospirenone—BCHE—obesity	9.12e-05	0.034	CrCbGaD
Spironolactone—Thrombocytopenia—Topiramate—obesity	9.09e-05	0.00161	CcSEcCtD
Spironolactone—ABCB1—adrenal gland—obesity	9.07e-05	0.00316	CbGeAlD
Spironolactone—Hydrocortamate—NR3C1—obesity	8.94e-05	0.0333	CrCbGaD
Spironolactone—Cortisone acetate—NR3C1—obesity	8.8e-05	0.0328	CrCbGaD
Spironolactone—Nausea—Bupropion—obesity	8.66e-05	0.00153	CcSEcCtD
Spironolactone—Fluoxymesterone—AR—obesity	8.49e-05	0.0317	CrCbGaD
Spironolactone—Megestrol acetate—NR3C1—obesity	8.48e-05	0.0316	CrCbGaD
Spironolactone—Medroxyprogesterone Acetate—SHBG—obesity	8.31e-05	0.031	CrCbGaD
Spironolactone—Somnolence—Topiramate—obesity	8.25e-05	0.00146	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Topiramate—obesity	8.01e-05	0.00142	CcSEcCtD
Spironolactone—ABCB1—endocrine gland—obesity	7.86e-05	0.00274	CbGeAlD
Spironolactone—Methyltestosterone—SHBG—obesity	7.82e-05	0.0292	CrCbGaD
Spironolactone—Feeling abnormal—Topiramate—obesity	7.65e-05	0.00136	CcSEcCtD
Spironolactone—Urticaria—Topiramate—obesity	7.38e-05	0.00131	CcSEcCtD
Spironolactone—Body temperature increased—Topiramate—obesity	7.34e-05	0.0013	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—AR—obesity	7.28e-05	0.0272	CrCbGaD
Spironolactone—ABCB1—liver—obesity	7.09e-05	0.00247	CbGeAlD
Spironolactone—Fludrocortisone—NR3C1—obesity	6.97e-05	0.026	CrCbGaD
Spironolactone—Methyltestosterone—AR—obesity	6.86e-05	0.0256	CrCbGaD
Spironolactone—Hypersensitivity—Topiramate—obesity	6.84e-05	0.00121	CcSEcCtD
Spironolactone—Pruritus—Topiramate—obesity	6.57e-05	0.00116	CcSEcCtD
Spironolactone—Fluoxymesterone—ESR1—obesity	6.54e-05	0.0244	CrCbGaD
Spironolactone—Diarrhoea—Topiramate—obesity	6.35e-05	0.00113	CcSEcCtD
Spironolactone—Dizziness—Topiramate—obesity	6.14e-05	0.00109	CcSEcCtD
Spironolactone—Vomiting—Topiramate—obesity	5.9e-05	0.00105	CcSEcCtD
Spironolactone—Hydrocortisone—SHBG—obesity	5.89e-05	0.022	CrCbGaD
Spironolactone—Rash—Topiramate—obesity	5.85e-05	0.00104	CcSEcCtD
Spironolactone—Dermatitis—Topiramate—obesity	5.85e-05	0.00104	CcSEcCtD
Spironolactone—Headache—Topiramate—obesity	5.82e-05	0.00103	CcSEcCtD
Spironolactone—Fluoxymesterone—NR3C1—obesity	5.76e-05	0.0215	CrCbGaD
Spironolactone—Methyltestosterone—CYP19A1—obesity	5.74e-05	0.0214	CrCbGaD
Spironolactone—Medroxyprogesterone Acetate—ESR1—obesity	5.61e-05	0.0209	CrCbGaD
Spironolactone—Nausea—Topiramate—obesity	5.51e-05	0.000977	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—NR3C1—obesity	4.94e-05	0.0184	CrCbGaD
Spironolactone—Progesterone—SHBG—obesity	4.8e-05	0.0179	CrCbGaD
Spironolactone—Progesterone—SLC22A1—obesity	4.74e-05	0.0177	CrCbGaD
Spironolactone—Testosterone—SHBG—obesity	4.54e-05	0.0169	CrCbGaD
Spironolactone—Testosterone—SLC22A1—obesity	4.48e-05	0.0167	CrCbGaD
Spironolactone—Progesterone—AR—obesity	4.21e-05	0.0157	CrCbGaD
Spironolactone—Drospirenone—PTGS2—obesity	4.2e-05	0.0157	CrCbGaD
Spironolactone—Testosterone—AR—obesity	3.98e-05	0.0148	CrCbGaD
Spironolactone—Hydrocortisone—NR3C1—obesity	3.5e-05	0.0131	CrCbGaD
Spironolactone—Testosterone—CYP19A1—obesity	3.33e-05	0.0124	CrCbGaD
Spironolactone—Progesterone—ESR1—obesity	3.24e-05	0.0121	CrCbGaD
Spironolactone—Progesterone—NR3C1—obesity	2.85e-05	0.0106	CrCbGaD
Spironolactone—Methyltestosterone—ALB—obesity	2.35e-05	0.00877	CrCbGaD
Spironolactone—Testosterone—ALB—obesity	1.36e-05	0.00509	CrCbGaD
Spironolactone—CYP11B2—Metabolism—PTGS2—obesity	3.75e-06	6.05e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—G6PD—obesity	3.75e-06	6.05e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PRKCD—obesity	3.75e-06	6.04e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CD—obesity	3.75e-06	6.04e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HK1—obesity	3.71e-06	5.97e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SREBF2—obesity	3.71e-06	5.97e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CD36—obesity	3.7e-06	5.97e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—APOB—obesity	3.7e-06	5.96e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ALB—obesity	3.7e-06	5.96e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HTR2A—obesity	3.67e-06	5.92e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—UCP3—obesity	3.67e-06	5.91e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ECHS1—obesity	3.67e-06	5.91e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HSD11B1—obesity	3.67e-06	5.91e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—UCP2—obesity	3.67e-06	5.91e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—C3—obesity	3.67e-06	5.91e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ADH1B—obesity	3.61e-06	5.82e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—LPA—obesity	3.58e-06	5.77e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPARGC1B—obesity	3.55e-06	5.72e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GPAM—obesity	3.55e-06	5.72e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ACSL1—obesity	3.55e-06	5.72e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—GNB3—obesity	3.55e-06	5.71e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3R1—obesity	3.54e-06	5.7e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—NOS3—obesity	3.54e-06	5.7e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—LPL—obesity	3.53e-06	5.69e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—HMOX1—obesity	3.53e-06	5.69e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—LPIN1—obesity	3.5e-06	5.65e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IRS2—obesity	3.49e-06	5.62e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PPARG—obesity	3.48e-06	5.61e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AGT—obesity	3.48e-06	5.61e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—GNAS—obesity	3.45e-06	5.56e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PCK1—obesity	3.45e-06	5.56e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—FADS1—obesity	3.45e-06	5.56e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HADH—obesity	3.45e-06	5.56e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GPX1—obesity	3.45e-06	5.55e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—obesity	3.44e-06	5.55e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APOA5—obesity	3.43e-06	5.53e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—LEP—obesity	3.41e-06	5.5e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APOE—obesity	3.41e-06	5.5e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—obesity	3.38e-06	5.45e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CAV1—obesity	3.38e-06	5.45e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—APOB—obesity	3.38e-06	5.45e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—obesity	3.38e-06	5.44e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APOA1—obesity	3.37e-06	5.44e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CD36—obesity	3.36e-06	5.41e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ACP5—obesity	3.36e-06	5.41e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PRKCD—obesity	3.34e-06	5.37e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—AGT—obesity	3.33e-06	5.37e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC22A1—obesity	3.27e-06	5.28e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CLOCK—obesity	3.27e-06	5.28e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—G6PD—obesity	3.27e-06	5.27e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—obesity	3.27e-06	5.26e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CB—obesity	3.27e-06	5.26e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ESR1—obesity	3.26e-06	5.25e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—obesity	3.24e-06	5.22e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTGS2—obesity	3.24e-06	5.21e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HK1—obesity	3.23e-06	5.2e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SREBF2—obesity	3.23e-06	5.2e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—obesity	3.23e-06	5.2e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PRKCB—obesity	3.22e-06	5.19e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—F2—obesity	3.22e-06	5.19e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PPARA—obesity	3.2e-06	5.15e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SULT2A1—obesity	3.19e-06	5.14e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GLP1R—obesity	3.19e-06	5.14e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—BAD—obesity	3.18e-06	5.12e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—MTHFR—obesity	3.18e-06	5.12e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—obesity	3.15e-06	5.08e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—DPYD—obesity	3.14e-06	5.06e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—SERPINE1—obesity	3.14e-06	5.06e-05	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—MYC—obesity	3.13e-06	5.04e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PPARA—obesity	3.12e-06	5.03e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—LPA—obesity	3.12e-06	5.03e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CG—obesity	3.08e-06	4.96e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—LPIN1—obesity	3.05e-06	4.92e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IRS1—obesity	3.04e-06	4.91e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PRKAR2B—obesity	3.02e-06	4.87e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AGT—obesity	3.02e-06	4.87e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—DCN—obesity	3e-06	4.83e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APOA5—obesity	2.99e-06	4.82e-05	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—AKT1—obesity	2.97e-06	4.78e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—APOE—obesity	2.96e-06	4.77e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—obesity	2.95e-06	4.75e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CAV1—obesity	2.93e-06	4.73e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—POMC—obesity	2.93e-06	4.72e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—APOA1—obesity	2.93e-06	4.72e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CPT1A—obesity	2.92e-06	4.7e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—INS—obesity	2.92e-06	4.7e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ESR1—obesity	2.9e-06	4.67e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	2.87e-06	4.63e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCL2—obesity	2.87e-06	4.62e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NAMPT—obesity	2.86e-06	4.61e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC22A1—obesity	2.85e-06	4.6e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CLOCK—obesity	2.85e-06	4.6e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—PPARA—obesity	2.85e-06	4.6e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—obesity	2.85e-06	4.58e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—LIPC—obesity	2.84e-06	4.58e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GCK—obesity	2.84e-06	4.58e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APOC3—obesity	2.83e-06	4.55e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IGF1—obesity	2.82e-06	4.54e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKT2—obesity	2.82e-06	4.54e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—obesity	2.81e-06	4.52e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.8e-06	4.52e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SULT2A1—obesity	2.78e-06	4.48e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GLP1R—obesity	2.78e-06	4.48e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CETP—obesity	2.74e-06	4.42e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—DPYD—obesity	2.74e-06	4.41e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SDC1—obesity	2.71e-06	4.37e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CD—obesity	2.71e-06	4.36e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SERPINE1—obesity	2.68e-06	4.32e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—APOA1—obesity	2.68e-06	4.31e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CG—obesity	2.67e-06	4.31e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKR1C3—obesity	2.67e-06	4.3e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PPARG—obesity	2.64e-06	4.26e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PRKAR2B—obesity	2.63e-06	4.24e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SCARB1—obesity	2.63e-06	4.23e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—DCN—obesity	2.61e-06	4.21e-05	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MYC—obesity	2.61e-06	4.2e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TYK2—obesity	2.61e-06	4.2e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—obesity	2.59e-06	4.18e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RHOA—obesity	2.58e-06	4.16e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PPARG—obesity	2.58e-06	4.16e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—obesity	2.56e-06	4.12e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3R1—obesity	2.56e-06	4.12e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NOS3—obesity	2.56e-06	4.12e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SREBF1—obesity	2.55e-06	4.11e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—POMC—obesity	2.54e-06	4.1e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CPT1A—obesity	2.54e-06	4.1e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—INS—obesity	2.53e-06	4.08e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NAMPT—obesity	2.49e-06	4.02e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GOT2—obesity	2.48e-06	4e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—LIPC—obesity	2.48e-06	3.99e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GCK—obesity	2.48e-06	3.99e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APOC3—obesity	2.46e-06	3.97e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—obesity	2.45e-06	3.94e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—FASN—obesity	2.43e-06	3.91e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—BCHE—obesity	2.42e-06	3.9e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CETP—obesity	2.39e-06	3.85e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—SERPINE1—obesity	2.38e-06	3.84e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SDC1—obesity	2.36e-06	3.81e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CB—obesity	2.36e-06	3.8e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MTOR—obesity	2.36e-06	3.8e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CD—obesity	2.35e-06	3.78e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—obesity	2.35e-06	3.78e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP2E1—obesity	2.33e-06	3.76e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKR1C3—obesity	2.33e-06	3.75e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ALB—obesity	2.32e-06	3.74e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CA—obesity	2.31e-06	3.72e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NQO1—obesity	2.31e-06	3.72e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SCARB1—obesity	2.29e-06	3.69e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—obesity	2.26e-06	3.64e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—obesity	2.24e-06	3.61e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SREBF1—obesity	2.22e-06	3.58e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NOS3—obesity	2.22e-06	3.57e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3R1—obesity	2.22e-06	3.57e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GCG—obesity	2.21e-06	3.56e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC2A4—obesity	2.21e-06	3.56e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYCS—obesity	2.18e-06	3.52e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GOT2—obesity	2.16e-06	3.48e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GGT1—obesity	2.14e-06	3.45e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GOT1—obesity	2.14e-06	3.45e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ALB—obesity	2.12e-06	3.42e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—FASN—obesity	2.12e-06	3.41e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NCOA1—obesity	2.11e-06	3.4e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—BCHE—obesity	2.11e-06	3.39e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP19A1—obesity	2.08e-06	3.35e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—STK11—obesity	2.08e-06	3.35e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MMP9—obesity	2.05e-06	3.31e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CB—obesity	2.05e-06	3.3e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP2E1—obesity	2.03e-06	3.28e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTGS2—obesity	2.03e-06	3.27e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NQO1—obesity	2.01e-06	3.24e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAPK8—obesity	2e-06	3.21e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CA—obesity	1.99e-06	3.21e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MYC—obesity	1.99e-06	3.2e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—COMT—obesity	1.93e-06	3.12e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GCG—obesity	1.93e-06	3.1e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC2A4—obesity	1.93e-06	3.1e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPARGC1A—obesity	1.91e-06	3.07e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GNB3—obesity	1.91e-06	3.07e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYCS—obesity	1.9e-06	3.06e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HMOX1—obesity	1.9e-06	3.06e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—AKT1—obesity	1.89e-06	3.04e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GGT1—obesity	1.87e-06	3.01e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GOT1—obesity	1.87e-06	3.01e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GNAS—obesity	1.86e-06	2.99e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NCOA1—obesity	1.84e-06	2.96e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—STAT3—obesity	1.82e-06	2.94e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APOB—obesity	1.82e-06	2.93e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—STK11—obesity	1.81e-06	2.92e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP19A1—obesity	1.81e-06	2.92e-05	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—AKT1—obesity	1.81e-06	2.91e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—LPL—obesity	1.74e-06	2.8e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MYC—obesity	1.7e-06	2.73e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GPX1—obesity	1.69e-06	2.73e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TGFB1—obesity	1.69e-06	2.72e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—COMT—obesity	1.68e-06	2.71e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GNB3—obesity	1.66e-06	2.68e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPARGC1A—obesity	1.66e-06	2.68e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HMOX1—obesity	1.65e-06	2.66e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CD36—obesity	1.65e-06	2.66e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—AKT1—obesity	1.63e-06	2.62e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GNAS—obesity	1.62e-06	2.61e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APOB—obesity	1.58e-06	2.55e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—MTHFR—obesity	1.56e-06	2.52e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPARA—obesity	1.53e-06	2.47e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—LPL—obesity	1.51e-06	2.44e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MYC—obesity	1.51e-06	2.43e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AGT—obesity	1.48e-06	2.39e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GPX1—obesity	1.48e-06	2.38e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APOE—obesity	1.45e-06	2.34e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CAV1—obesity	1.44e-06	2.32e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CA—obesity	1.44e-06	2.32e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APOA1—obesity	1.44e-06	2.32e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CD36—obesity	1.44e-06	2.32e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—AKT1—obesity	1.38e-06	2.22e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.38e-06	2.22e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MTHFR—obesity	1.36e-06	2.19e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPARA—obesity	1.34e-06	2.15e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CG—obesity	1.31e-06	2.12e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AGT—obesity	1.29e-06	2.08e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL6—obesity	1.27e-06	2.05e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APOE—obesity	1.27e-06	2.04e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPARG—obesity	1.27e-06	2.04e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CAV1—obesity	1.26e-06	2.02e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APOA1—obesity	1.25e-06	2.02e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—POMC—obesity	1.25e-06	2.01e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CA—obesity	1.25e-06	2.01e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—INS—obesity	1.24e-06	2e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKT1—obesity	1.18e-06	1.89e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CD—obesity	1.15e-06	1.86e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CG—obesity	1.14e-06	1.84e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ALB—obesity	1.14e-06	1.84e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPARG—obesity	1.1e-06	1.78e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3R1—obesity	1.09e-06	1.76e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NOS3—obesity	1.09e-06	1.76e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—POMC—obesity	1.09e-06	1.75e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—INS—obesity	1.08e-06	1.74e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—AKT1—obesity	1.04e-06	1.68e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AKT1—obesity	1.02e-06	1.64e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CB—obesity	1.01e-06	1.62e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CD—obesity	1.01e-06	1.62e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS2—obesity	9.97e-07	1.61e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ALB—obesity	9.93e-07	1.6e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3R1—obesity	9.5e-07	1.53e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NOS3—obesity	9.5e-07	1.53e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CB—obesity	8.77e-07	1.41e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS2—obesity	8.69e-07	1.4e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CA—obesity	6.13e-07	9.88e-06	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CA—obesity	5.34e-07	8.61e-06	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKT1—obesity	5.01e-07	8.07e-06	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKT1—obesity	4.37e-07	7.03e-06	CbGpPWpGaD
